NewAmsterdam Capital Expenditures from 2010 to 2025

NAMS Stock   23.50  0.30  1.26%   
NewAmsterdam Pharma Capital Expenditures yearly trend continues to be comparatively stable with very little volatility. Capital Expenditures is likely to outpace its year average in 2025. From the period from 2010 to 2025, NewAmsterdam Pharma Capital Expenditures quarterly data regression had r-value of  0.58 and coefficient of variation of  233.77. View All Fundamentals
 
Capital Expenditures  
First Reported
2010-12-31
Previous Quarter
672 K
Current Value
705.6 K
Quarterly Volatility
230.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NewAmsterdam Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewAmsterdam Pharma's main balance sheet or income statement drivers, such as Net Interest Income of 17.7 M, Interest Income of 17.7 M or Interest Expense of 0.0, as well as many indicators such as Price To Sales Ratio of 33.94, Dividend Yield of 0.0 or PTB Ratio of 3.36. NewAmsterdam financial statements analysis is a perfect complement when working with NewAmsterdam Pharma Valuation or Volatility modules.
  
Check out the analysis of NewAmsterdam Pharma Correlation against competitors.
For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.

Latest NewAmsterdam Pharma's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of NewAmsterdam Pharma over the last few years. Capital Expenditures are funds used by NewAmsterdam Pharma to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of NewAmsterdam Pharma operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is NewAmsterdam Pharma's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewAmsterdam Pharma's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

NewAmsterdam Capital Expenditures Regression Statistics

Arithmetic Mean98,600
Geometric Mean22,792
Coefficient Of Variation233.77
Mean Deviation147,550
Median13,000
Standard Deviation230,493
Sample Variance53.1B
Range692.6K
R-Value0.58
Mean Square Error37.7B
R-Squared0.34
Significance0.02
Slope28,126
Total Sum of Squares796.9B

NewAmsterdam Capital Expenditures History

2025705.6 K
2024672 K
202324 K
202120 K

About NewAmsterdam Pharma Financial Statements

NewAmsterdam Pharma shareholders use historical fundamental indicators, such as Capital Expenditures, to determine how well the company is positioned to perform in the future. Although NewAmsterdam Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in NewAmsterdam Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on NewAmsterdam Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Expenditures672 K705.6 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.